Menu

CME Corner

This activity has expired. CME/CE credit is no longer available and the following content may not be available or may not be up-to-date. For a list of current activities that offer CME/CE credit, click here.

Program Detail

Release Date: April-19-13
Credit Expiration Date: April-18-14

Faculty

Gary W. Small, MD
Parlow-Solomon Professor on Aging
Professor of Psychiatry & Biobehavioral Sciences
David Geffen School of Medicine at UCLA
Director, UCLA Longevity Center
Director, Geriatric Psychiatry Division Semel Institute for Neuroscience and Human Behavior
Stewart & Lynda Resnick Neuropsychiatric Hospital
Los Angeles, CA

Credit Hours

0.50 AMA PRA Category 1 Credit

Medium

Mobile + Online on QuantiaMD

Program Description

Alzheimer’s disease (AD) is the most common cause of dementia, with 4.6 million new cases diagnosed each year. The high incidence and prevalence of AD, combined with a lack of treatments that halt or reverse AD symptoms, translates into a significant burden. This burden is expected to increase, not only because more and more individuals are living longer, but also because diagnosis and treatment of this condition are fraught with challenges. This activity will provide an update in contemporary AD diagnosis, management, and treatment for primary care clinicians.

Program Developer/Facilitator


.

Target Audience

This educational activity is designed to meet the needs of primary care physicians, NPs, PAs, and nurses treating patients with Alzheimer’s disease in the community setting.

Learning Objectives

Upon completion of this educational activity, the participant should be able to:

  1. Discuss strategies for identifying early AD
  2. Identify methods of ensuring each patient receives and adheres to AD treatment designed to manage their specific symptoms
  3. Discuss how emerging targets and therapies and non-medical strategies may impact clinical management of patients with AD in the primary care setting

Disclosures

It is policy at the Perelman School of Medicine at the University of Pennsylvania for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provides products or services that may be relevant to the content of this continuing medical education activity.

Dr. Small discloses the following relationships with the commercial interests:
Pfizer, Honorarium, Advisor
Janssen, Honorarium, Advisor
Novartis, Honorarium, Advisor

U of Penn Office of CME:
Zalman S. Agus, MD, has no relevant financial relationships to disclose.
Ms. Mila Kostic has no relevant financial relationships to disclose.
Michael Schoen, PhD, has no relevant financial relationships to disclose.

MCM Education:
Ms. Kathleen Hines has no relevant financial relationships to disclose.

Investigational and/or Off-Label Use of Commercial Products and Devices: The Perelman School of Medicine at the University of Pennsylvania requires all faculty to disclose any planned discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.
In this educational activity, the faculty reports his presentation will contain reference to investigational and/or off-label uses of Cholinesterase inhibitors for MIC.

Credit Statements

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Perelman School of Medicine at the University of Pennsylvania and MCM Education. The Perelman School of Medicine at the University of Pennsylvania is accredited by the ACCME to provide continuing medical education for physicians.

The Perelman School of Medicine at the University of Pennsylvania designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Release date: April 19, 2013
Last review date: April 19, 2013
Expiration date: April 18, 2014

Commercial Support Statements

Supported by independent educational grants from Baxter and GE Healthcare.

Instructions

Completion Instructions

  1. Accessing Activity:
    * Link to and Log into program on QuantiaMD.com
    * Take the pre-test
    * Review the activity
    * Take the post-test and score 75%
    * You are allowed two retakes
    * Complete the evaluation
    * View, print, or save a CME certificate verifying your
    credit/participation in this activity
  2. Computer Requirements: Minimum System Requirements: • Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7 • Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers

Certificate Fee

$0.00

There is no charge for CME credit.

Disclaimer

© 2013, MCM Education. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, the Perelman School of Medicine at the University of Pennsylvania, Baxter, or GE Healthcare. Any medications, diagnostic procedures, or treatments discussed by the faculty should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.

By clicking START PROGRAM I acknowledge that I have read the CME/CE information above.

Main Menu
EDITOR'S PICKS